TSC2 and head and neck squamous cell carcinoma: Moreover, neddylation of tuberous sclerosis complex 2 (TSC2) inactivates the mTOR pathway, enhancing migration, invasion, and EMT in head and neck squamous cell carcinoma (HNSCC) [29].